Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study
Titel:
Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study
Auteur:
Kantarjian, Hagop M DeAngelo, Daniel J Advani, Anjali S Stelljes, Matthias Kebriaei, Partow Cassaday, Ryan D Merchant, Akil A Fujishima, Naohito Uchida, Toshiki Calbacho, Maria Ejduk, Anna A O'Brien, Susan M Jabbour, Elias J Zhang, Hui Sleight, Barbara J Vandendries, Erik R Marks, David I